Roles for Dual Endothelin-1Angiotensin II Receptor (DEAR) in hypertension and angiogenesis

Details for Australian Patent Application No. 2005307765 (hide)

International Classifications

Event Publications

21 June 2007 PCT application entered the National Phase

PCT publication WO2006/055665 Priority application(s): WO2006/055665

28 June 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 25 May 2007

21 April 2011 Application Accepted

Published as AU-B-2005307765

12 May 2011 Corrigenda

Applications Accepted - Name Index Under the name Trustees of Boston University, Application No. 2005307765, under INID (54) correct the title to read Roles for Dual Endothelin-/1Angiotensin II Receptor (DEAR) in hypertension and angiogenesis

19 May 2011 Corrigenda

Applications Accepted - Name Index Under the name Trustees of Boston University, Application No. 2005307765, under INID (54) correct the title to read Roles for Dual Endothelin-1/Angiotensin II Receptor (DEAR) in hypertension and angiogenesis

18 August 2011 Standard Patent Sealed

23 February 2012 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 05 Jan 2012. Address for service in Australia - Pizzeys Patent and Trade Mark Attorneys Level 20 324 Queen Street Brisbane QLD 4000 2006

5 July 2012 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 05 Jan 2012 2006 2006202085 OM Pharma The nature of the amendment is as shown in the statement(s) filed 28 Feb 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.